Geron Corp

NASDAQ: GERN
Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 149 COMMONWEALTH DRIVE, SUITE 2070, MENLO PARK, CA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 1,227.33M USD
Shares Outstanding 543,064,000
Geron Corp is a biopharmaceutical company focused on developing treatments for blood cancers. Its main project, imetelstat, is a groundbreaking therapy aimed at stopping the spread of cancerous cells in certain blood disorders. This innovative drug is currently in advanced testing stages, showing promise for patients with specific types of myelodysplastic syndromes and myelofibrosis. Founded in 1990 and based in Foster City, California, Geron is at the forefront of research in telomerase inhibition, a novel approach in cancer treatment.
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning.Apple Inc. (NASDAQ: AAPL) Reiterated Buy and raised target to $500 at...
Biotech is about to become even less of a diversified sector due to mergers and acquisitions. Genzyme Corporation (NASDAQ: GENZ) and Cephalon Inc. (NASDAQ: CEPH) will end up accounting for about $30...
Active traders and day traders have many stocks to choose from this morning.  We are tracking news and moves in shares of Some of the most active stocks or largest moves seen in shares of...
The world of biotech and biohealth is seeing a flurry of news today.  This is bringing on many winners and losers in the sector.  We are tracking the news and the moves in Alexza Pharmaceuticals...
Active traders and day traders have many stocks to choose from this morning.  We are tracking moves in Celldex Therapeutics, Inc. (NASDAQ: CLDX), Gymboree Corp. (NASDAQ: GYMB), Geron Corporation...
This weekend’s edition of The Unusual Suspects is different.  While some earnings focus is made, there are several key events coming up that investors and traders alike will want to watch. ...
Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there has been on a single day in months and months.  The news is not even on any of the...
There are several big stocks to watch this morning.  Day traders and active traders will want to watch McDonald’s Corporation (NYSE: MCD), ARM Holdings plc (NASDAQ: ARMH), Geron Corporation...
Stem cell stocks are getting hit pretty hard this Tuesday.  On Monday came a ruling from a U.S. district judge which effectively blocks the federal government from funding research which involves...
There are many stocks on the move for day traders and active traders to pick from this Monday morning.  We are watching the key moves in Administaff Inc. (NYSE: ASF), Arena Pharmaceuticals, Inc....
Day traders and active traders have many stocks on the move to choose from this Friday.  Some of the top percentage movers and standout stocks are Alcatel-Lucent (NYSE: ALU), Coinstar Inc. (NASDAQ:...
This morning’s top day trader and active trader alerts are part on earnings and part on other news. The cast of characters this Thursday morning are  BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX),...
These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this morning: Amazon.com Inc. (NASDAQ: AMZN) Started as Buy at Stifel...
We have many stocks on the move this morning pre-market.  Some of the big percentage changes are being seen in Ambac Financial Group, Inc. (NYSE: ABK), ChipMOS TECHNOLOGIES LTD. (NASDAQ: IMOS),...
Stem cell stocks (tracked in Tickerspy’s Stem Cell Stock’s Index (*RXSTM) are up over 7% today, led by Athersys Inc (NASDAQ: ATHX).  Athersys Inc. rose as high as 395% this morning...